Skip to content

5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects.

Maurizio Coppola, Raffaella Mondola

Toxicology Letters March 27, 2013 DOI: 10.1016/j.toxlet.2013.01.008 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics MDMA
Citations 20
Key findings 5-IAI, a rigid analogue of p-iodoamphetamine producing MDMA-like effects, was identified in recreational products in the UK in 2011.

Abstract

In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical, pharmacological, and toxicological information about this new potential drug of abuse.

Comparable studies

Other narrative reviews on MDMA, most cited first.

Citations in the library

Explore topics